Genmab A/S Stock

Genmab A/S DSCR

The Debt Service Coverage Ratio (DSCR) of Genmab A/S (GMAB.CO) as of Aug 8, 2026 is 0.22. In the previous year, Debt Service Coverage Ratio (DSCR) was 7.89 — a change of -97.23% (lower).

DSCR

0.22

YoY

-97.23%

Last updated:

Debt Service Coverage Ratio (DSCR) of Genmab A/S is 2026 0.22 . Debt Service Coverage Ratio (DSCR) of Genmab A/S was 2025 7.89 . It decreases by -97.23% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Debt Service Coverage Ratio (DSCR) of Genmab A/S is 0.22 in 2026.

Debt Service Coverage Ratio (DSCR) of Genmab A/S changed from 7.89 to 0.22, representing a -97.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s Genmab A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Genmab A/S

All Key Metrics — Genmab A/S